Nu Skin Enterprises Inc Net Assets
Nu Skin Enterprises Inc net assets. Based on the latest financial reports, Nu Skin Enterprises Inc (NUS) has net assets worth $542.74 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.12 Billion) and total liabilities ($578.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See NUS equity to assets ratio to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $542.74 Million |
| % of Total Assets | 48.39% |
| Annual Growth Rate | 8.93% |
| 5-Year Change | -11.78% |
| 10-Year Change | 21.26% |
| Growth Volatility | 22.94 |
Net Assets of Nu Skin Enterprises Inc (1995–2025)
Net assets of Nu Skin Enterprises Inc from 1995 to 2025. This chart illustrates how Nu Skin Enterprises Inc's net assets have evolved over time, based on quarterly financial data. Also explore Nu Skin Enterprises Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Net Assets for Nu Skin Enterprises Inc (1995–2025)
The table below shows the annual net assets of Nu Skin Enterprises Inc from 1995 to 2025. For live market cap and overall valuation, see Nu Skin Enterprises Inc market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $805.24 Million | +23.61% |
| 2024-12-31 | $651.46 Million | -20.74% |
| 2023-12-31 | $821.97 Million | -8.40% |
| 2022-12-31 | $897.30 Million | -1.70% |
| 2021-12-31 | $912.77 Million | +2.07% |
| 2020-12-31 | $894.27 Million | +2.17% |
| 2019-12-31 | $875.29 Million | +11.95% |
| 2018-12-31 | $781.87 Million | +10.97% |
| 2017-12-31 | $704.60 Million | +6.10% |
| 2016-12-31 | $664.07 Million | -19.57% |
| 2015-12-31 | $825.62 Million | -12.40% |
| 2014-12-31 | $942.44 Million | +9.76% |
| 2013-12-31 | $858.62 Million | +45.38% |
| 2012-12-31 | $590.61 Million | +2.85% |
| 2011-12-31 | $574.24 Million | +21.85% |
| 2010-12-31 | $471.25 Million | +25.44% |
| 2009-12-31 | $375.69 Million | +18.82% |
| 2008-12-31 | $316.18 Million | +14.97% |
| 2007-12-31 | $275.01 Million | -13.78% |
| 2006-12-31 | $318.98 Million | -10.05% |
| 2005-12-31 | $354.63 Million | +19.71% |
| 2004-12-31 | $296.23 Million | +2.06% |
| 2003-12-31 | $290.25 Million | -24.90% |
| 2002-12-31 | $386.49 Million | +1.74% |
| 2001-12-31 | $379.89 Million | +3.59% |
| 2000-12-31 | $366.73 Million | +18.53% |
| 1999-12-31 | $309.40 Million | +21.52% |
| 1998-12-31 | $254.60 Million | +43.44% |
| 1997-12-31 | $177.50 Million | +64.66% |
| 1996-12-31 | $107.80 Million | +74.43% |
| 1995-12-31 | $61.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nu Skin Enterprises Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2990.2% over the analyzed period, indicating profitable operations and earnings retention.
Nu Skin Enterprises Inc Net Assets Breakdown (December 2025)
Nu Skin Enterprises Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.86 Billion | 231.03% |
| Common Stock | $91.00K | 0.01% |
| Other Comprehensive Income | $-116.11 Million | -14.42% |
| Total Equity | $805.24 Million | 100.00% |
Nu Skin Enterprises Inc Competitors by Market Cap
The table below lists competitors of Nu Skin Enterprises Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UEM Edgenta Bhd
KLSE:1368
|
$229.67 Million |
|
Kardan Israel Ltd
TA:KRDI
|
$229.76 Million |
|
Hubtown Limited
NSE:HUBTOWN
|
$229.82 Million |
|
Solstice Minerals Ltd
AU:SLS
|
$229.83 Million |
|
Nampak
JSE:NPK
|
$229.56 Million |
|
Bitcoin Infrastructure Acquisition Corp Ltd. Class A Ordinary Shares
NASDAQ:BIXI
|
$229.52 Million |
|
SIGA Technologies Inc
NASDAQ:SIGA
|
$229.52 Million |
|
Rectron Ltd
TW:2302
|
$229.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nu Skin Enterprises Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 651,455,000 to 805,240,000, a change of 153,785,000 (23.6%).
- Net income of 160,204,000 contributed positively to equity growth.
- Dividend payments of 11,834,000 reduced retained earnings.
- Share repurchases of 20,040,000 reduced equity.
- Other comprehensive income increased equity by 8,653,000.
- Other factors increased equity by 16,802,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $160.20 Million | +19.9% |
| Dividends Paid | $11.83 Million | -1.47% |
| Share Repurchases | $20.04 Million | -2.49% |
| Other Comprehensive Income | $8.65 Million | +1.07% |
| Other Changes | $16.80 Million | +2.09% |
| Total Change | $- | 23.61% |
Book Value vs Market Value Analysis
This analysis compares Nu Skin Enterprises Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.30x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 6.15x to 0.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.77 | $4.73 | x |
| 1996-12-31 | $1.30 | $4.73 | x |
| 1997-12-31 | $2.03 | $4.73 | x |
| 1998-12-31 | $2.93 | $4.73 | x |
| 1999-12-31 | $3.52 | $4.73 | x |
| 2000-12-31 | $4.28 | $4.73 | x |
| 2001-12-31 | $4.53 | $4.73 | x |
| 2002-12-31 | $4.65 | $4.73 | x |
| 2003-12-31 | $3.65 | $4.73 | x |
| 2004-12-31 | $4.08 | $4.73 | x |
| 2005-12-31 | $4.97 | $4.73 | x |
| 2006-12-31 | $4.52 | $4.73 | x |
| 2007-12-31 | $4.19 | $4.73 | x |
| 2008-12-31 | $4.93 | $4.73 | x |
| 2009-12-31 | $5.84 | $4.73 | x |
| 2010-12-31 | $7.30 | $4.73 | x |
| 2011-12-31 | $8.90 | $4.73 | x |
| 2012-12-31 | $9.37 | $4.73 | x |
| 2013-12-31 | $13.97 | $4.73 | x |
| 2014-12-31 | $15.48 | $4.73 | x |
| 2015-12-31 | $13.98 | $4.73 | x |
| 2016-12-31 | $11.84 | $4.73 | x |
| 2017-12-31 | $12.85 | $4.73 | x |
| 2018-12-31 | $13.84 | $4.73 | x |
| 2019-12-31 | $15.65 | $4.73 | x |
| 2020-12-31 | $16.95 | $4.73 | x |
| 2021-12-31 | $17.75 | $4.73 | x |
| 2022-12-31 | $17.76 | $4.73 | x |
| 2023-12-31 | $16.49 | $4.73 | x |
| 2024-12-31 | $13.12 | $4.73 | x |
| 2025-12-31 | $16.01 | $4.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nu Skin Enterprises Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.90%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.79%
- • Asset Turnover: 1.06x
- • Equity Multiplier: 1.75x
- Recent ROE (19.90%) is below the historical average (24.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 65.05% | 11.21% | 3.03x | 1.91x | $34.02 Million |
| 1996 | 75.79% | 12.04% | 2.05x | 3.08x | $70.92 Million |
| 1997 | 52.73% | 10.51% | 2.53x | 1.99x | $75.85 Million |
| 1998 | 40.81% | 11.37% | 1.51x | 2.38x | $78.44 Million |
| 1999 | 28.02% | 9.70% | 1.39x | 2.08x | $55.76 Million |
| 2000 | 16.82% | 7.01% | 1.49x | 1.61x | $25.03 Million |
| 2001 | 13.24% | 5.68% | 1.52x | 1.53x | $12.32 Million |
| 2002 | 16.78% | 6.73% | 1.58x | 1.58x | $26.19 Million |
| 2003 | 23.39% | 6.88% | 1.58x | 2.15x | $38.85 Million |
| 2004 | 26.22% | 6.83% | 1.87x | 2.06x | $48.05 Million |
| 2005 | 20.88% | 6.27% | 1.74x | 1.91x | $38.57 Million |
| 2006 | 10.29% | 2.94% | 1.68x | 2.08x | $919.00K |
| 2007 | 15.95% | 3.79% | 1.69x | 2.48x | $16.37 Million |
| 2008 | 20.67% | 5.24% | 1.76x | 2.24x | $33.73 Million |
| 2009 | 23.91% | 6.75% | 1.78x | 1.99x | $52.28 Million |
| 2010 | 28.87% | 8.85% | 1.72x | 1.89x | $88.93 Million |
| 2011 | 26.70% | 8.79% | 1.76x | 1.73x | $95.91 Million |
| 2012 | 37.53% | 10.22% | 1.88x | 1.95x | $162.58 Million |
| 2013 | 42.50% | 11.49% | 1.74x | 2.12x | $279.03 Million |
| 2014 | 20.07% | 7.36% | 1.59x | 1.71x | $94.93 Million |
| 2015 | 16.11% | 5.92% | 1.49x | 1.82x | $50.48 Million |
| 2016 | 21.55% | 6.48% | 1.50x | 2.22x | $76.68 Million |
| 2017 | 18.37% | 5.68% | 1.43x | 2.26x | $58.98 Million |
| 2018 | 15.59% | 4.55% | 1.58x | 2.17x | $43.70 Million |
| 2019 | 19.83% | 7.17% | 1.37x | 2.02x | $86.02 Million |
| 2020 | 21.40% | 7.41% | 1.32x | 2.19x | $101.93 Million |
| 2021 | 16.13% | 5.46% | 1.41x | 2.09x | $55.99 Million |
| 2022 | 11.68% | 4.71% | 1.22x | 2.03x | $15.05 Million |
| 2023 | 1.05% | 0.44% | 1.09x | 2.20x | $-73.60 Million |
| 2024 | -22.50% | -8.46% | 1.18x | 2.25x | $-211.74 Million |
| 2025 | 19.90% | 10.79% | 1.06x | 1.75x | $79.68 Million |
Industry Comparison
This section compares Nu Skin Enterprises Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $653,229,035
- Average return on equity (ROE) among peers: -496.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nu Skin Enterprises Inc (NUS) | $542.74 Million | 65.05% | 1.07x | $229.64 Million |
| Acme United Corporation (ACU) | $35.01 Million | 11.44% | 0.94x | $158.51 Million |
| Instinct Bio Technical Company Holdings Inc. Ordinary Shares (BIOT) | $2.31 Million | 23.61% | 0.48x | $5.78 Million |
| Bruush Oral Care Inc. (BRSHF) | $163.14K | -5449.60% | 11.70x | $20.19K |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $1.51 Million | 31.78% | 1.05x | $12.69 Million |
| Church & Dwight Company Inc (CHD) | $1.98 Billion | 23.21% | 1.20x | $24.49 Billion |
| Colgate-Palmolive Company (CL) | $350.30 Million | 367.77% | 19.23x | $73.48 Billion |
| The Clorox Company (CLX) | $616.40 Million | 17.02% | 0.51x | $10.56 Billion |
| Coty Inc (COTY) | $3.56 Billion | 7.29% | 2.41x | $2.51 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-4.71 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $-4.58 Million | 0.00% | 0.00x | $4.19 Million |
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and… Read more